Allen C. Puwalski, CFA

Cybiont Capital, LLC                August 2019 – Present

Founding Partner, CIO

“Deep fundamental experience codified.” Fundamental, rules-driven, investment platform for Bank stocks to provide uncorrelated, absolute returns with low volatility. Long/Short equity strategy.

 SoFi                                March 2020 – July 2021

Head of Community Bank Strategy

Building partnerships and long-term mutually beneficial relationships with America’s community banks to unlock trapped value for all by providing access to scale in consumer lending and digital banking and building a distributed funding source for SoFi.

Neocova                          March 2019 – September 2021

Strategic Advisor

A financial technology company serving community banks with cloud-native core banking systems and AI-driven compliance systems.

Paulson & Co. Inc.      November 2007 – March 2018

Partner, Head of Global Banks (named Co-Portfolio Manager in 2015)

Established $1 billion+ in early short positions in subsequently bankrupt global financial companies with unsustainable underwriting models. Generated large position ($100 million plus), long ideas in the financials sector, post GFC. Long positions in banks were the largest contributor to fund performance in 2009 and 2010. Lead role managing PE consortium purchasing IndyMac Bank from the FDIC.  Managed $50 billion notional-value bank credit default swap (CDS) portfolio. Invested in complex debt for equity swap in Greek Bank resulting in 0.2x TBV entry price.

OneWest Bank, NA                                         2009 – 2015

Director (Audit and Compensation Committees)

Purchased IndyMac FSB out of receivership in partnership with Steven Mnuchin, J.C. Flowers and others. Earned 3.2x return on $1.6 billion invested.  Invested capital returned fully by 5th year of investment. Guided two assisted bank acquisitions and the conversion to a national bank charter.  Transformed the company from a subprime mortgage lender to a commercial bank. Sold the bank to CIT in 2015 creating the first new systemically important financial institution since the designation was created. Managed bank through a mortgage servicing consent order.

Financial Accounting Standards Board                                       2010 – 2014

FASAC (Financial Accounting Strategic Advisory Council) Member

Representing financial statement users, advise the FASB on issues related to financial accounting standards in effect or needed.

CFRA (Center for Financial Research & Analysis)                                                             2004 – 2007

Financial Sector Lead & Team Leader

Built out financial sector coverage for this leading subscription-based forensic research provider. Positioned CFRA to sell to Riskmetrics in August 2007.  Led early identification and analysis of subprime mortgage short opportunities.

FDIC                                                    1991 – 2004

Chief, Bank Analysis (Bank Examiner & Capital Markets Specialist)

Managed analysis, publications, and policy development of a 15-person multi-disciplinary team of PhD economists, CPAs, CFAs, and commissioned bank examiners. Bank failure projection modeling, early development of bank stress testing, derivatives risk, and quantitative underpinnings for risk-based deposit insurance pricing. Five years as a field examiner in MD and the FDIC’s New York Region.

About Us

We are your banking experts.

Private Equity: We are a trusted partner for family offices and other investors seeking to invest in U.S. banks in the private markets. We source investment opportunities and provide diligence services and ongoing monitoring of bank investments for family offices and other investors for whom we provide cost-effective confidence for their financial company investments.

Public Markets: We structure bank investment portfolios providing risk-tailored strategies by systematically integrating fundamental and technical analysis building alpha-generating long/short portfolios from the nearly 300 liquid publicly traded banking companies in the U.S. markets. If you want bank equity exposure with tailored risk parameter’s, we’re your source.

Cybiont is…

Our Investment Philosophy

Recieve Cybiont’s analysis in your email as it’s released: